Abivax S.A. (ABVX) Free Cash Flow (2024 - 2026)

Abivax (ABVX) has reported Free Cash Flow for 3 consecutive years, with $63220.3 the latest figure, recorded in Q1 2026.

• In Q1 2026, Free Cash Flow rose 100.18% year-over-year to $63220.3; the TTM figure through Mar 2026 stood at -$148.2 million (up 9.97% YoY), while the FY2025 annual figure was -$187.7 million, down 13.51% from the prior year.
• Free Cash Flow came in at $63220.3 for Q1 2026 at Abivax, up from -$27.2 million in the prior quarter.
• The five-year high for Free Cash Flow was $63220.3 in Q1 2026, with the low at -$83.3 million in Q3 2025.
• Average Free Cash Flow over 3 years is -$39.0 million, with a median of -$37.7 million recorded in 2025.
• Across the five-year window, Free Cash Flow slumped 116.38% in 2025 and jumped 100.18% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at -$37.1 million in 2024, then climbed by 26.62% to -$27.2 million in 2025, then soared by 100.23% to $63220.3 in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $63220.3, -$27.2 million, and -$83.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.